386 related articles for article (PubMed ID: 34280256)
1. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
[TBL] [Abstract][Full Text] [Related]
2. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia.
Huynh A; Arnold DM; Ivetic N; Clare R; Hadzi-Tosev M; Liu Y; Smith JW; Bissola AL; Daka M; Kelton JG; Nazy I
J Thromb Haemost; 2023 Oct; 21(10):2833-2843. PubMed ID: 37394121
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
5. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R
J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms of vaccine-induced thrombosis.
Marietta M; Coluccio V; Luppi M
Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
Greinacher A; Warkentin TE
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Aspects of VITT.
Schönborn L; Greinacher A
Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
[TBL] [Abstract][Full Text] [Related]
10. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
11. Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis.
Passariello M; Vetrei C; Amato F; De Lorenzo C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445266
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
[TBL] [Abstract][Full Text] [Related]
13. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
[TBL] [Abstract][Full Text] [Related]
15. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
[TBL] [Abstract][Full Text] [Related]
16. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
[TBL] [Abstract][Full Text] [Related]
17. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.
Handtke S; Wolff M; Zaninetti C; Wesche J; Schönborn L; Aurich K; Ulm L; Hübner NO; Becker K; Thiele T; Greinacher A
Blood; 2021 Jul; 137(26):3656-3659. PubMed ID: 33945605
[TBL] [Abstract][Full Text] [Related]
18. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.
Schönborn L; Thiele T; Kaderali L; Günther A; Hoffmann T; Seck SE; Selleng K; Greinacher A
Blood; 2022 Mar; 139(12):1903-1907. PubMed ID: 35113987
[TBL] [Abstract][Full Text] [Related]
19. Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating
Konstantinou GN
Hum Vaccin Immunother; 2022 Nov; 18(5):2050654. PubMed ID: 35412949
[TBL] [Abstract][Full Text] [Related]
20. Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodies.
Schönborn L; Thiele T; Esefeld M; El Debuch K; Wesche J; Seck SE; Kaderali L; Wolff M; Warkentin TE; Greinacher A
J Thromb Haemost; 2022 Nov; 20(11):2579-2586. PubMed ID: 36006172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]